Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Solomon

Showing results (181-190 of 208) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Molecular testing for the clinical diagnosis of fibrolamellar carcinomaRondell P Graham, Matthew M Yeh, Dora Lam-Himlin, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2022
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-GangliogliomaCalixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
Cell|January 19, 2024
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspectiveRadhika Mathur, Qixuan Wang, Patrick G Schupp, et al.
Nature Communications|February 25, 2018
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricleBenjamin Goode, Gourish Mondal, Michael Hyun, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
Pageof 21

Showing results (181-190 of 208) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|April 29, 2017
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapyCassie N Kline, Nancy M Joseph, James P Grenert, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|September 2, 2017
Molecular testing for the clinical diagnosis of fibrolamellar carcinomaRondell P Graham, Matthew M Yeh, Dora Lam-Himlin, et al.
Journal of Neuropathology and Experimental Neurology|June 15, 2022
Targeted Next-Generation Sequencing Reveals Divergent Clonal Evolution in Components of Composite Pleomorphic Xanthoastrocytoma-GangliogliomaCalixto-Hope G Lucas, Christian J Davidson, Mouied Alashari, et al.
Neuro-Oncology|November 1, 2020
A subset of pediatric-type thalamic gliomas share a distinct DNA methylation profile, H3K27me3 loss and frequent alteration of EGFRPhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
Cell|January 19, 2024
Glioblastoma evolution and heterogeneity from a 3D whole-tumor perspectiveRadhika Mathur, Qixuan Wang, Patrick G Schupp, et al.
Nature Communications|February 25, 2018
A recurrent kinase domain mutation in PRKCA defines chordoid glioma of the third ventricleBenjamin Goode, Gourish Mondal, Michael Hyun, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Neuro-Oncology|November 19, 2024
Longitudinal multimodal profiling of IDH-wildtype glioblastoma reveals the molecular evolution and cellular phenotypes underlying prognostically different treatment responsesCalixto-Hope G Lucas, Nadeem N Al-Adli, Jacob S Young, et al.
Pageof 21